LncRNA HOST2 promotes NSUN2-mediated breast cancer progression via interaction with ELAVL1
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study reveals that HOST2 blocks ELAVL1 degradation, stabilizing NSUN2 mRNA and promoting breast cancer (BC) progression. Targeting the HOST2/ELAVL1/NSUN2 pathway offers a potential new therapeutic strategy for BC.
Area Of Science
- Oncology
- Molecular Biology
- RNA Biology
Background
- Breast cancer (BC) is a leading cause of cancer-related mortality in women globally.
- NSUN2, an RNA methyltransferase, is implicated in tumor cell proliferation and metastasis.
- Elevated NSUN2 expression correlates with poor prognosis in breast cancer patients.
Purpose Of The Study
- To elucidate the regulatory mechanism of NSUN2 in breast cancer progression.
- To identify key molecules involved in NSUN2 mRNA stability.
- To explore the potential of the HOST2/ELAVL1/NSUN2 axis as a therapeutic target for breast cancer.
Main Methods
- Analysis of NSUN2 expression in breast cancer tissues and cell lines.
- In vitro and in vivo experiments involving NSUN2 knockout in breast cancer cells.
- Investigation of RNA-binding protein ELAVL1 interactions with NSUN2 mRNA.
- Identification of long non-coding RNA HOST2's role in ELAVL1 protein stability.
Main Results
- NSUN2 is upregulated in breast cancer and associated with poor patient outcomes.
- NSUN2 knockout inhibits breast cancer cell proliferation and migration.
- ELAVL1 binds to NSUN2 mRNA, enhancing its stability.
- HOST2 prevents ELAVL1's proteasomal degradation, thus stabilizing NSUN2 mRNA.
Conclusions
- The study identifies a novel HOST2/ELAVL1/NSUN2 signaling pathway crucial for breast cancer progression.
- HOST2 stabilizes NSUN2 mRNA by inhibiting ELAVL1 degradation.
- This pathway represents a promising novel therapeutic target for breast cancer treatment.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...